Clinical Connection

This trial is not actively recruiting.

This trial has completed recruitment on this platform, and is no longer accepting new referrals.

MOUNTAINEER: A Clinical Trial for HER2+ Metastatic Colorectal Cancer

A study to test the safety and effectiveness of the combination of tucatinib and trastuzumab in people with HER2+ metastatic or unresectable colorectal cancer

Trial ID: NCT03043313

Trial Details

Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.

Estimated Enrollment

115 Participants

Phase

2

Eligibility Criteria

Participants must:

This trial is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.

Participants must not:

This trial is no longer recruiting participants. Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.

What Will Happen in the Study?

Please visit https://clinicaltrials.gov/study/NCT03043313 for more information.

Frequently Asked Questions (FAQs)